This study is testing a new medicine called DISC-0974 for adults with chronic kidney disease (CKD) and anemia. Anemia is when your blood doesn't have enough healthy red blood cells. The study will see how safe DISC-0974 is and how it works in the body, which is known as pharmacokinetics (PK) and pharmacodynamics (PD). Participants must have CKD that doesn't require dialysis, and low levels of hemoglobin (a protein in red blood cells).

3 Key Points:

• Duration & Visits: The study is in Phase 1b, meaning it's in early stages of testing. It will require several visits for check-ups and monitoring.
• Eligibility: Patients must be 18 or older, have CKD, and meet specific health criteria, like certain blood levels.
• Exclusions: Participants can't have used certain anemia treatments recently, have recent serious health issues, or be pregnant.

If you're interested, you'll need to stop taking iron supplements a few days before joining. This study can help develop new treatments for CKD patients with anemia, but it's important to consider your health and any risks before joining.